Dealing with chest mucus can be uncomfortable, causing coughing and difficulty breathing. Fortunately, several natural ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...
Johnson & Johnson reported that Spravato treated over 100,000 patients in 77 countries worldwide, including roughly 80,000 in ...
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
We have made great strides in the medical community, with people having access to life-saving physical drugs as well as ...
Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is ...
“With the global nasal spray market projected to reach over $23 billion by 2029 ... Manufacturing Organization (CDMO), Eurofins CDMO offers a powerful network of companies across Europe, North America ...
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...